Heron Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HRTX and other ETFs, options, and stocks.

About HRTX

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. 

CEO
Craig A. Collard
CEOCraig A. Collard
Employees
126
Employees126
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1983
Founded1983
Employees
126
Employees126

HRTX Key Statistics

Market cap
452.49M
Market cap452.49M
Price-Earnings ratio
-2.98
Price-Earnings ratio-2.98
Dividend yield
—
Dividend yield—
Average volume
1.80M
Average volume1.80M
High today
$3.01
High today$3.01
Low today
$2.67
Low today$2.67
Open price
$2.70
Open price$2.70
Volume
1.88M
Volume1.88M
52 Week high
$3.22
52 Week high$3.22
52 Week low
$0.50
52 Week low$0.50

HRTX News

Seeking Alpha 7d
Heron Therapeutics: Zynrelef Eases Shareholder Pain - Seeking Alpha

Jeremy Edwards/E+ via Getty Images Heron Therapeutics (NASDAQ:HRTX) has seen a positive start to 2024, with approval of the company's supplemental New Drug App...

Heron Therapeutics: Zynrelef Eases Shareholder Pain - Seeking Alpha
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.